Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2 | 2.13 |
NAV | ₹1380.91 | ₹27.98 |
Fund Started | 12 Apr 1994 | 28 May 2019 |
Fund Size | ₹3775.16 Cr | ₹1692.67 Cr |
Exit Load | Exit load of 1%, if redeemed within 90 days. | Exit load of 1% if redeemed within 12 months. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | -1.40% | -3.95% |
3 Year | 14.99% | 15.54% |
5 Year | 13.58% | 22.66% |
1 Year
3 Year
5 Year
Equity | 98.52% | 96.10% |
Cash | 1.48% | 3.32% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Maruti Suzuki India Ltd. | 5.40% |
Bayer CropScience Ltd. | 4.30% |
Schaeffler India Ltd. | 3.73% |
United Breweries Ltd. | 3.39% |
Cummins India Ltd. | 3.22% |
Hindustan Unilever Ltd. | 3.07% |
Honeywell Automation India Ltd. | 3.01% |
Crisil Ltd. | 2.97% |
ICRA Ltd. | 2.95% |
Gillette India Ltd. | 2.75% |
Name | Assets |
---|---|
Maruti Suzuki India Ltd. | 8.99% |
Hindustan Unilever Ltd. | 8.26% |
Sun Pharmaceutical Industries Ltd. | 6.49% |
Vedanta Ltd. | 4.21% |
Gland Pharma Ltd. | 3.67% |
Hyundai Motor India Ltd. | 3.15% |
Nestle India Ltd. | 2.98% |
United Breweries Ltd. | 2.97% |
Britannia Industries Ltd. | 2.81% |
Zydus Lifesciences Ltd. | 2.47% |
Name | Dhaval Joshi | Roshan Chutkey |
Start Date | 21 Nov 2022 | 23 Nov 2020 |
Name
Start Date
Description | The scheme would invest exclusively in securities of multinational companies in order to achieve long term growth of capital at relatively moderate levels of risk. A portion of the fund will also be invested in IPO and other primary market offerings. | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities within MNC space. |
Launch Date | 12 Apr 1994 | 28 May 2019 |
Description
Launch Date